TB-500 / KPV / BPC-157
SKU：tb500-kpv-bpc157
Price：USD 160.00
Product information
This 30 mg blend contains TB-500, KPV and BPC-157 at 10 mg each. Its separate ingredient research backgrounds concern actin-related cell movement, NF-kB inflammatory signalling and growth-factor or angiogenesis pathways. Comparing combined conditions against individual compounds is the experimental rationale. This comparative approach does not validate a combined clinical or tissue-repair effect.
Product specifications
- Components
- TB-500 (Thymosin Beta-4) + KPV + BPC-157
- Content
- 30 mg per vial (10 mg of each component)
- TB-500 Fragment
- 43-amino acid active region of Tβ4
- KPV Sequence
- Lys-Pro-Val (α-MSH 11-13)
- BPC-157 Sequence
- 15 amino acids (Gly-Glu-Pro-Pro-Pro...)
- Form
- Lyophilized powder blend
- Purity
- ≥99% per component (HPLC verified)
- Testing
- Third-party HPLC, Mass Spec, Endotoxin
- Storage
- -20°C for long-term stability
- Solubility
- Water-soluble
- Label amount
- 30mg
Analysis report
TB-500 / KPV / BPC-157 30mg · 30mg · 8HEX09
Research information
Read the full TB-500 / KPV / BPC-157 research monograph
Research overview
This 30 mg blend contains TB-500, KPV and BPC-157 at 10 mg each. Its separate ingredient research backgrounds concern actin-related cell movement, NF-kB inflammatory signalling and growth-factor or angiogenesis pathways. Comparing combined conditions against individual compounds is the experimental rationale. This comparative approach does not validate a combined clinical or tissue-repair effect.